Skip to content

Patch trial for pain relief after gynaecological surgeries

Efficacy of Lignocaine 5% Transdermal Patch for Acute Postoperative Pain control in Gynaecological Cancer Patients following Lower Abdominal Surgeries A Pilot Randomised Control Trial - Patch

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107607
Enrollment
20
Registered
2026-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Lignocaine patches 5 percent: Lignocaine patches 5%, cut into two parts and each part will be put at 1cm from incision on either side along the length of incision. Maximum 2 patches wil

Sponsors

ACTRECTMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients 18 to 60 years Lower abdominal midline incision extending up-to T8 dermatome i.e. extending above umbilicus by 2to5 cm ASA I toII Able to understand and use pain scales

Exclusion criteria

Exclusion criteria: Allergy to amide local anaesthetics, NSAIDs, Paracetamol Significant hepatic, renal, or cardiac dysfunction Major resections that require extending incision beyond T8 level Chronic pain or long-term analgesic use Local skin disease preventing patch use

Design outcomes

Primary

MeasureTime frame
To assess and compare the total opioid consumption in first 72 hours among two groups (Lignocaine patch group/ Regional catheters group) of patients undergoing open lower abdominal surgeriesTimepoint: At baseline, upto 72hrs post operatively

Secondary

MeasureTime frame
To assess and compare mean pain scores,patient satisfaction scores,Incidence of Post operative nausea vomiting (PONV), Post-op ileus, Percentage of incentive spirometry achieved Timepoint: At baseline, upto 72hrs post operatively;Complications associated with regional catheters (Leakage, dislodgement, Blockage)Timepoint: At baseline, upto 72hrs post operatively;Complications associated with lignocaine 5% patch (Erythema, itching)Timepoint: At baseline, upto 72hrs post operatively

Countries

India

Contacts

Public ContactDr Bhakti Deshmukh

Tata Memorial Hospital

rambulkar@hotmail.com9821790448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026